Stage III Non–Small-Cell Lung Cancer Treated With Concurrent Chemoradiation Followed or Not by Consolidation Chemotherapy: A Survival Analysis From a Brazilian Multicentric Cohort

PURPOSE: Of newly diagnosed patients with non–small-cell lung cancer (NSCLC), stage III accounts for 30%. Most patients are treated with concurrent chemoradiation therapy, but the addition of consolidation chemotherapy (CC) is debatable. We examined the effect of CC in Brazilian patients with stage...

Descripción completa

Detalles Bibliográficos
Autores principales: Cordeiro de Lima, Vladmir C., Baldotto, Clarissa S., Barrios, Carlos H., Sobrinho, Eldsamira M., Zukin, Mauro, Mathias, Clarissa, Zaffaroni, Facundo, Nery, Rodrigo C., Madeira, Gabriel, Amadio, Alex V., Coelho, Juliano C., Geib, Guilherme, Simões, Maria Fernanda, Castro, Gilberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Clinical Oncology 2018
Materias:
Original Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6223524/
https://www.ncbi.nlm.nih.gov/pubmed/30241276
http://dx.doi.org/10.1200/JGO.17.00214

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6223524/
https://www.ncbi.nlm.nih.gov/pubmed/30241276
http://dx.doi.org/10.1200/JGO.17.00214

Ejemplares similares